特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
939198

感染症診断:世界市場の展望(2018-2027年)

Infectious Disease Diagnostics - Global Market Outlook (2018-2027)

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 131 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.64円
感染症診断:世界市場の展望(2018-2027年)
出版日: 2020年05月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 131 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の感染症診断の市場は予測期間中7.1%のCAGRで推移し、2018年の155億3000万米ドルから、2027年には287億9000万米ドルの規模に成長すると予測されています。感染症有病率の増加、新技術の開発とR&D活動の活発化、感染症抑制のための新たな診断検査の増加などの要因が同市場の成長を推進しています。しかし一方で、熟練した技術者・専門家の不足や、デバイスの高コスト性が市場のさらなる成長を抑制しています。

当レポートでは、世界の感染症診断の市場を調査し、市場および技術の概要、市場成長への各種影響因子および市場機会の分析、製品&サービス・技術・検査タイプ・疾患区分・エンドユーザー・地域/主要国など各種区分別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向の分析

  • イントロダクション
  • 促進要因
  • 抑制要因
  • 市場機会
  • 脅威
  • 技術分析
  • エンドユーザー分析
  • 新興市場
  • Covid-19の影響

第4章 ポーターのファイブフォース分析

第5章 世界の感染症診断市場:製品・サービス別

  • イントロダクション
  • アッセイ・キット・試薬
  • 機器
  • ソフトウェア

第6章 世界の感染症診断市場:検査タイプ別

  • イントロダクション
  • 生検
  • 画像検査
  • 臨床検査

第7章 世界の感染症診断市場:技術別

  • イントロダクション
  • 生化学的特性評価
  • 臨床微生物学
  • 従来技術
  • DNAマイクロアレイ
  • DNAシーケンス&次世代シーケンス(NGS)
  • ハイブリダイゼーション・マイクロアレイ
  • 免疫診断
  • 等温核酸増幅技術(INAAT)
  • 顕微鏡
  • 分子技術
  • POC感染症診断検査
  • ポリメラーゼ連鎖反応(PCR)

第8章 世界の感染症診断市場:疾患区分別

  • イントロダクション
  • 後天性免疫不全症候群(AIDS)
  • 細菌感染
  • 心血管感染症
  • クラミジア性器感染症・淋病(CT / NG)
  • コロナウイルス
  • 腺熱
  • 肝炎
  • 院内感染(HAIS)
  • ヒト免疫不全ウイルス(HIV)
  • ヒトパピローマウイルス(HPV)
  • インフルエンザ
  • メチシリン耐性黄色ブドウ球菌(MRSA)
  • 結核(TB)
  • その他

第9章 世界の感染症診断市場:エンドユーザー別

  • イントロダクション
  • 学術/ 調査機関
  • 外来手術センター
  • 血液バンク
  • 受託調査機関
  • 診断クリニック
  • 在宅ヘルスケア
  • 病院/臨床検査室
  • 養護施設
  • 医師オフィス
  • リファレンスラボ

第10章 世界の感染症診断市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • 南米
  • 中東・アフリカ

第11章 主な展開

  • 契約・提携・協力・JV
  • M&A
  • 新製品の発売
  • 拡張
  • その他の主要戦略

第12章 企業プロファイル

  • Abbott Diagnostic
  • Alere
  • Beckman Coulter
  • Becton, Dickinson and Company (BD)
  • bioMerieux
  • Bio-Rad Laboratories
  • Cavidi
  • Cepheid
  • Corgenix
  • Diasorin
  • Diaxonhit
  • Eiken Chemical
  • EMD Millipore
  • J.Mitra
  • Meridian Bioscience
  • Roche Diagnostic
  • Siemens Healthcare Diagnostics
  • TECHLAB
  • Thermo Fisher Scientific
  • Trinity Biotech
図表

List of Tables

  • Table 1 Global Infectious Disease Diagnostics Market Outlook, By Region (2017-2027) ($MN)
  • Table 2 Global Infectious Disease Diagnostics Market Outlook, By Product & Service (2017-2027) ($MN)
  • Table 3 Global Infectious Disease Diagnostics Market Outlook, By Assays, Kits, & Reagents (2017-2027) ($MN)
  • Table 4 Global Infectious Disease Diagnostics Market Outlook, By Instruments (2017-2027) ($MN)
  • Table 5 Global Infectious Disease Diagnostics Market Outlook, By Software (2017-2027) ($MN)
  • Table 6 Global Infectious Disease Diagnostics Market Outlook, By Test Type (2017-2027) ($MN)
  • Table 7 Global Infectious Disease Diagnostics Market Outlook, By Biopsies (2017-2027) ($MN)
  • Table 8 Global Infectious Disease Diagnostics Market Outlook, By Imaging Test (2017-2027) ($MN)
  • Table 9 Global Infectious Disease Diagnostics Market Outlook, By Laboratory Tests (2017-2027) ($MN)
  • Table 10 Global Infectious Disease Diagnostics Market Outlook, By Technology (2017-2027) ($MN)
  • Table 11 Global Infectious Disease Diagnostics Market Outlook, By Biochemical Characterization (2017-2027) ($MN)
  • Table 12 Global Infectious Disease Diagnostics Market Outlook, By Clinical Microbiology (2017-2027) ($MN)
  • Table 13 Global Infectious Disease Diagnostics Market Outlook, By Conventional Techniques (2017-2027) ($MN)
  • Table 14 Global Infectious Disease Diagnostics Market Outlook, By DNA Microarray (2017-2027) ($MN)
  • Table 15 Global Infectious Disease Diagnostics Market Outlook, By DNA Sequencing & Next-Generation Sequencing (NGS) (2017-2027) ($MN)
  • Table 16 Global Infectious Disease Diagnostics Market Outlook, By Hybridization and Microarrays (2017-2027) ($MN)
  • Table 17 Global Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2017-2027) ($MN)
  • Table 18 Global Infectious Disease Diagnostics Market Outlook, By Isothermal Nucleic Acid Amplification Technology (INAAT) (2017-2027) ($MN)
  • Table 19 Global Infectious Disease Diagnostics Market Outlook, By Microscopy (2017-2027) ($MN)
  • Table 20 Global Infectious Disease Diagnostics Market Outlook, By Molecular Techniques (2017-2027) ($MN)
  • Table 21 Global Infectious Disease Diagnostics Market Outlook, By POC infectious disease diagnostics test (2017-2027) ($MN)
  • Table 22 Global Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2017-2027) ($MN)
  • Table 23 Global Infectious Disease Diagnostics Market Outlook, By Disease Type (2017-2027) ($MN)
  • Table 24 Global Infectious Disease Diagnostics Market Outlook, By Acquired Immunodeficiency Syndrome (AIDS) (2017-2027) ($MN)
  • Table 25 Global Infectious Disease Diagnostics Market Outlook, By Bacterial Infection (2017-2027) ($MN)
  • Table 26 Global Infectious Disease Diagnostics Market Outlook, By Cardiovascular infection (2017-2027) ($MN)
  • Table 27 Global Infectious Disease Diagnostics Market Outlook, By Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG) (2017-2027) ($MN)
  • Table 28 Global Infectious Disease Diagnostics Market Outlook, By Coronavirus (2017-2027) ($MN)
  • Table 29 Global Infectious Disease Diagnostics Market Outlook, By Glandular fever (2017-2027) ($MN)
  • Table 30 Global Infectious Disease Diagnostics Market Outlook, By Hepatitis (2017-2027) ($MN)
  • Table 31 Global Infectious Disease Diagnostics Market Outlook, By Hospital-Acquired Infections (HAIS) (2017-2027) ($MN)
  • Table 32 Global Infectious Disease Diagnostics Market Outlook, By Human Immunodeficiency Virus (HIV) (2017-2027) ($MN)
  • Table 33 Global Infectious Disease Diagnostics Market Outlook, By Human Papillomavirus (HPV) (2017-2027) ($MN)
  • Table 34 Global Infectious Disease Diagnostics Market Outlook, By Influenza (2017-2027) ($MN)
  • Table 35 Global Infectious Disease Diagnostics Market Outlook, By Methicillin-resistant Staphylococcus Aureus (MRSA) (2017-2027) ($MN)
  • Table 36 Global Infectious Disease Diagnostics Market Outlook, By Tuberculosis (TB) (2017-2027) ($MN)
  • Table 37 Global Infectious Disease Diagnostics Market Outlook, By Other Disease Types (2017-2027) ($MN)
  • Table 38 Global Infectious Disease Diagnostics Market Outlook, By End User (2017-2027) ($MN)
  • Table 39 Global Infectious Disease Diagnostics Market Outlook, By Academic/Research Institutes (2017-2027) ($MN)
  • Table 40 Global Infectious Disease Diagnostics Market Outlook, By Ambulatory Surgical Centers (2017-2027) ($MN)
  • Table 41 Global Infectious Disease Diagnostics Market Outlook, By Blood Banks (2017-2027) ($MN)
  • Table 42 Global Infectious Disease Diagnostics Market Outlook, By Contract Research Organization (2017-2027) ($MN)
  • Table 43 Global Infectious Disease Diagnostics Market Outlook, By Diagnostic Clinics (2017-2027) ($MN)
  • Table 44 Global Infectious Disease Diagnostics Market Outlook, By Home healthcare (2017-2027) ($MN)
  • Table 45 Global Infectious Disease Diagnostics Market Outlook, By Hospital/Clinical Laboratories (2017-2027) ($MN)
  • Table 46 Global Infectious Disease Diagnostics Market Outlook, By Nursing Homes (2017-2027) ($MN)
  • Table 47 Global Infectious Disease Diagnostics Market Outlook, By Physician Offices (2017-2027) ($MN)
  • Table 48 Global Infectious Disease Diagnostics Market Outlook, By Reference Laboratories (2017-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

目次

According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $15.53 billion in 2018 and is expected to reach $28.79 billion by 2027 growing at a CAGR of 7.1% during the forecast period. Increasing prevalence of infectious diseases, growing R& D activities coupled with the development of novel technologies and rising new diagnostic tests for the control of infectious diseases are the major factors propelling the market growth. However, lack of skilled technicians/professionals and high cost of these devices is hampering the market growth.

Infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits. Any bacteria which cause infectious disease are called pathogens. Diagnosis for the causative organism of bacterial disease is always difficult since infections show symptoms like lethargy and fever.

Based on the technology, DNA sequencing & next-generation sequencing (NGS) segment is going to have a lucrative growth during the forecast period due to factors such as development in sequencing technologies, rising awareness and taking of personalized medicine in which this technology has major applications and growing application of molecular diagnostic technologies in pharmacogenetics and point-of-care testing are expected to boost the growth of this technology in the future. By geography, North America is likely to have a huge demand owing to extremely developed healthcare system, mounting prevalence of infectious diseases, the existence of a huge number of leading national clinical laboratories, and simple accessibility to technologically advanced devices in the region.

Some of the key players profiled in the Infectious Disease Diagnostics Market are Abbott Diagnostic, Alere, Beckman Coulter , Becton, Dickinson and Company (BD), bioMerieux, Bio-Rad Laboratories, Cavidi, Cepheid, Corgenix, Diasorin, Diaxonhit , Eiken Chemical, EMD Millipore, J.Mitra, Meridian Bioscience, Roche Diagnostic , Siemens Healthcare Diagnostics, TECHLAB, Thermo Fisher Scientific and Trinity Biotech.

Product & Services Covered:

  • Assays, Kits, & Reagents
  • Instruments
  • Software

Test Types Covered:

  • Biopsies
  • Imaging Test
  • Laboratory Tests

Technologies Covered:

  • Biochemical Characterization
  • Clinical Microbiology
  • Conventional Techniques
  • DNA Microarray
  • DNA Sequencing & Next-Generation Sequencing (NGS)
  • Hybridization and Microarrays
  • Immunodiagnostics
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Microscopy
  • Molecular Techniques
  • POC infectious disease diagnostics test
  • Polymerase Chain Reaction (PCR)

Disease Types Covered:

  • Acquired Immunodeficiency Syndrome (AIDS)
  • Bacterial Infection
  • Cardiovascular infection
  • Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG)
  • Coronavirus
  • Glandular fever
  • Hepatitis
  • Hospital-Acquired Infections (HAIS)
  • Human Immunodeficiency Virus (HIV)
  • Human Papillomavirus (HPV)
  • Influenza
  • Methicillin-resistant Staphylococcus Aureus (MRSA)
  • Tuberculosis (TB)
  • Other Disease Types

End Users Covered:

  • Academic/Research Institutes
  • Ambulatory Surgical Centers
  • Blood Banks
  • Contract Research Organization
  • Diagnostic Clinics
  • Home healthcare
  • Hospital/Clinical Laboratories
  • Nursing Homes
  • Physician Offices
  • Reference Laboratories

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Infectious Disease Diagnostics Market, By Product & Service

  • 5.1 Introduction
  • 5.2 Assays, Kits, & Reagents
  • 5.3 Instruments
  • 5.4 Software

6 Global Infectious Disease Diagnostics Market, By Test Type

  • 6.1 Introduction
  • 6.2 Biopsies
  • 6.3 Imaging Test
  • 6.4 Laboratory Tests

7 Global Infectious Disease Diagnostics Market, By Technology

  • 7.1 Introduction
  • 7.2 Biochemical Characterization
  • 7.3 Clinical Microbiology
  • 7.4 Conventional Techniques
  • 7.5 DNA Microarray
  • 7.6 DNA Sequencing & Next-Generation Sequencing (NGS)
  • 7.7 Hybridization and Microarrays
  • 7.8 Immunodiagnostics
  • 7.9 Isothermal Nucleic Acid Amplification Technology (INAAT)
  • 7.10 Microscopy
  • 7.11 Molecular Techniques
  • 7.12 POC infectious disease diagnostics test
  • 7.13 Polymerase Chain Reaction (PCR)

8 Global Infectious Disease Diagnostics Market, By Disease Type

  • 8.1 Introduction
  • 8.2 Acquired Immunodeficiency Syndrome (AIDS)
  • 8.3 Bacterial Infection
  • 8.4 Cardiovascular infection
  • 8.5 Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG)
  • 8.6 Coronavirus
  • 8.7 Glandular fever
  • 8.8 Hepatitis
  • 8.9 Hospital-Acquired Infections (HAIS)
  • 8.10 Human Immunodeficiency Virus (HIV)
  • 8.11 Human Papillomavirus (HPV)
  • 8.12 Influenza
  • 8.13 Methicillin-resistant Staphylococcus Aureus (MRSA)
  • 8.14 Tuberculosis (TB)
  • 8.15 Other Disease Types

9 Global Infectious Disease Diagnostics Market, By End User

  • 9.1 Introduction
  • 9.2 Academic/Research Institutes
  • 9.3 Ambulatory Surgical Centers
  • 9.4 Blood Banks
  • 9.5 Contract Research Organization
  • 9.6 Diagnostic Clinics
  • 9.7 Home healthcare
  • 9.8 Hospital/Clinical Laboratories
  • 9.9 Nursing Homes
  • 9.10 Physician Offices
  • 9.11 Reference Laboratories

10 Global Infectious Disease Diagnostics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Abbott Diagnostic
  • 12.2 Alere
  • 12.3 Beckman Coulter
  • 12.4 Becton, Dickinson and Company (BD)
  • 12.5 bioMerieux
  • 12.6 Bio-Rad Laboratories
  • 12.7 Cavidi
  • 12.8 Cepheid
  • 12.9 Corgenix
  • 12.10 Diasorin
  • 12.11 Diaxonhit
  • 12.12 Eiken Chemical
  • 12.13 EMD Millipore
  • 12.14 J.Mitra
  • 12.15 Meridian Bioscience
  • 12.16 Roche Diagnostic
  • 12.17 Siemens Healthcare Diagnostics
  • 12.18 TECHLAB
  • 12.19 Thermo Fisher Scientific
  • 12.20 Trinity Biotech
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.